Letting patients choose their HIV support shows promise in early trial
NCT ID NCT07439562
Summary
This study tests whether offering people a choice of support methods helps them stay in HIV care when starting or restarting medication. 140 adults in South Africa will be randomly assigned to receive standard care, in-person group support, or get to choose their support option (in-person groups, WhatsApp groups, or an AI chatbot). The research aims to see if having a choice makes the support more appealing and helps people stick with their treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV CARE LOSS TO FOLLOWUP are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gugulethu Community Health Centre
Cape Town, Western Cape, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.